72.31
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
The Cooper Companies, Inc. stock is traded at $72.31, with a volume of 2.09M.
It is down -0.47% in the last 24 hours and up +0.84% over the past month.
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women's health, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier screening, preimplantation genetic screening, and preimplantation genetic diagnosis used in IVF process; IVF medical devices, systems, and equipment; and PARAGARD, a non-hormonal, copper intrauterine device for birth control. Further, The Cooper Companies, Inc. offers its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
See More
Previous Close:
$72.65
Open:
$71.95
24h Volume:
2.09M
Relative Volume:
0.74
Market Cap:
$14.10B
Revenue:
$4.23B
Net Income/Loss:
$235.80M
P/E Ratio:
61.07
EPS:
1.1841
Net Cash Flow:
$569.50M
1W Performance:
+2.84%
1M Performance:
+0.84%
6M Performance:
-11.15%
1Y Performance:
+2.29%
The Cooper Companies, Inc. Stock (COO) Company Profile
Name
The Cooper Companies, Inc.
Sector
Industry
Phone
925-460-3600
Address
6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA
Compare COO vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COO
The Cooper Companies, Inc.
|
72.31 | 13.71B | 4.23B | 235.80M | 569.50M | 1.1841 |
|
ISRG
Intuitive Surgical Inc
|
353.33 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
165.70 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
68.94 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
39.28 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
211.00 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
The Cooper Companies, Inc. Stock (COO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-26 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Feb-03-26 | Reiterated | Needham | Buy |
| Nov-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-13-25 | Initiated | Barclays | Overweight |
| Oct-01-25 | Initiated | Goldman | Sell |
| Aug-28-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-22-25 | Upgrade | BNP Paribas Exane | Neutral → Outperform |
| Jun-17-25 | Upgrade | Needham | Hold → Buy |
| May-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-29-24 | Reiterated | Piper Sandler | Overweight |
| Jul-16-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-19-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Mar-13-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-30-23 | Initiated | BofA Securities | Buy |
| Oct-05-23 | Downgrade | Redburn Atlantic | Overweight → Neutral |
| May-30-23 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-30-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-12-22 | Downgrade | Jefferies | Buy → Hold |
| Aug-29-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-17-22 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-22 | Initiated | Needham | Hold |
| Jan-03-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-03-21 | Reiterated | Citigroup | Neutral |
| Sep-03-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-03-21 | Reiterated | Oppenheimer | Perform |
| Sep-03-21 | Reiterated | Stifel | Buy |
| Apr-23-21 | Initiated | Redburn | Buy |
| Jul-06-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-01-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-04-19 | Downgrade | Goldman | Neutral → Sell |
| Jul-30-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Dec-08-17 | Reiterated | Stifel | Buy |
| Sep-12-17 | Reiterated | Stifel | Buy |
| Sep-01-17 | Reiterated | Piper Jaffray | Overweight |
| Jul-21-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Jun-29-17 | Initiated | Guggenheim | Neutral |
| Jun-02-17 | Reiterated | Stifel | Buy |
| Dec-12-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-02-16 | Reiterated | BMO Capital Markets | Outperform |
| Aug-31-16 | Reiterated | Stifel | Buy |
| Jun-30-16 | Reiterated | Stifel | Buy |
| Jun-03-16 | Reiterated | Jefferies | Buy |
| Apr-15-16 | Upgrade | Jefferies | Hold → Buy |
| Dec-17-15 | Initiated | Goldman | Neutral |
| Dec-04-15 | Downgrade | JP Morgan | Overweight → Neutral |
View All
The Cooper Companies, Inc. Stock (COO) Latest News
UBS Initiates Cooper Companies at Neutral With $75 Price Target - marketscreener.com
Cooper Companies Inc (COO) Valuation: PE, PB & Fair Value Analysis - TradingKey
COO|Cooper Companies Inc|Price:70.300|Chg%:-0.010 - TradingKey
Cooper Companies Inc (COO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cooper Companies Inc (COO) Institutional Confidence - TradingKey
Cooper Companies Inc (COO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cooper Companies Inc (COO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cooper Companies Inc (COO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CooperCompanies stock steadies as contact lens growth supports earnings - Ad-hoc-news.de
Cooper Companies, Inc. Revenue Breakdown – FWB:CP60 - TradingView
Cooper Companies Inc (COO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cooper Companies Inc (COO) Cash Flow - TradingKey
COO|Cooper Companies Inc|Price:70.310|Chg%:+0.080 - TradingKey
Cooper Companies Inc (COO) Balance Sheet - TradingKey
The Cooper Companies, Inc. (CP60.DE) insider ownership and holdings - Yahoo Finance Singapore
Cooper Companies (COO) Stock Looks Weak On Returns Yet Rich On Earnings - Yahoo Finance
Did Cooper Companies' Q1 Beat Mask Underlying Weakness - Kavout | AI
CooperCompanies stock trades steadily as contact lens growth supports earnings - Ad-hoc-news.de
Cooper Companies Inc. R (CP60.DE) Q1 FY2026 earnings call transcript - Yahoo Finance
Cooper Companies, Inc. Revenue Breakdown – GETTEX:CP60 - TradingView
The Cooper Companies’ Q2 2026 Earnings: What to Expect - inkl
Cooper Companies Inc (COO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CooperCompanies stock steadies as investors weigh Vision and fertility growth - Ad-hoc-news.de
CooperCompanies stock trades steadily as vision care growth supports earnings - Ad-hoc-news.de
The Cooper Companies, Inc. (COO) Stock Analysis: Unpacking A 13.92% Potential Upside - DirectorsTalk Interviews
Reasons to retain Cooper Companies stock in your portfolio for now - MSN
CooperCompanies stock trades steadily as contact lens demand supports revenue growth - AD HOC NEWS
CooperCompanies stock trades steady as contact lens demand supports earnings momentum - Ad-hoc-news.de
The Cooper Companies, Inc. Stock 12‑Month Price Target Cut to $81.25, Implies 11% Upside - TradingView
CooperCompanies stock trades steady as recent earnings highlight growth in contact lenses and women� - AD HOC NEWS
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now - Yahoo Finance
CooperCompanies Releases 2025 Corporate Sustainability Report With Scope 3 Emissions Disclosure - VisionMonday.com
Pullback Created an Attractive Entry Point in The Cooper Companies (COO) - Yahoo Finance
Brown Advisory Sustainable Value Fund's The Cooper Companies Inc(COO) Holding History - GuruFocus
The Cooper Companies Inc (COO) Shares Fall 3.9% -- What GF Score of 89 Tells Investors - GuruFocus
Goldman Sachs Adjusts Price Target on Cooper Companies to $63 From $66, Maintains Sell Rating - Moomoo
CooperCompanies stock holds steady as a specialized medtech player with a global footprint - Ad-hoc-news.de
CooperCompanies stock stays supported by contact lens demand - Ad-hoc-news.de
Citi Maintains Cooper Companies(COO.US) With Hold Rating, Raises Target Price to $76 - Moomoo
CooperCompanies stock stays supported by steady medical demand - ad-hoc-news.de
CooperVision Strengthens Professional Affairs, Myopia Management Functions With Leadership Appointments - VisionMonday.com
A Look at The Cooper Companies Inc (COO) After 3.2% Decline -- G - GuruFocus
The Cooper Companies grows its healthcare footprint. Vision and fertility drive long-term demand - Ad-hoc-news.de
The Cooper Companies highlights eye care growth as investors watch US exposure - ad-hoc-news.de
CooperCompanies highlights specialty contact lenses as long-term demand driver - Ad-hoc-news.de
CooperVision Names Muru Annamalai as President, Asia-Pacific - AOL.com
CooperCompanies reports double-digit pay increase for its median employee - Medical Design & Outsourcing
The Cooper Companies updates investors. Medical devices group navigates vision care demand - Ad-hoc-news.de
CooperCompanies outlines growth plans as demand for vision care stays resilient - ad-hoc-news.de
CooperSurgical IVF LawsuitEmbryo Loss LawsuitJune 2026 - AboutLawsuits.com
Mid Value Fund's The Cooper Companies Inc(COO) Holding History - GuruFocus
The Cooper Companies, Inc. Stock (COO) Financials Data
Revenue
Net Income
Cash Flow
EPS
The Cooper Companies, Inc. Stock (COO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WEISS ROBERT S | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,654 |
0 |
292,599 |
| Rivas Maria | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
3,322 |
| Jay Colleen | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
39,907 |
| Carbone Barbara | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,050 |
0 |
3,050 |
| MADDEN TERESA S | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
15,679 |
| Lucchese Cynthia L | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
12,767 |
| Kurzius Lawrence Erik | Director |
Apr 01 '26 |
Option Exercise |
0.00 |
3,322 |
0 |
11,099 |
| Jay Colleen | Director |
Jan 12 '26 |
Option Exercise |
39.40 |
7,064 |
278,322 |
36,585 |
| White Albert G III | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
18,340 |
0 |
254,491 |
| Warner Gerard H III | President, CooperVision, Inc. |
Jan 08 '26 |
Option Exercise |
0.00 |
11,518 |
0 |
29,837 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):